Hanmi's PPI-type drug for reflux esophagitis treatment Esomezol has received the spotlight from abroad
Hanmi's PPI-type drug for reflux esophagitis treatment Esomezol has received the spotlight from abroad
(Yakup Shinmoon)
Hanmi's PPI-type drug for reflux esophagitis treatment Esomezol (Incrementally modified drug) which made successful entry into the U.S., has received the spotlight from abroad...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
